Picture of Biofrontera AG logo

B8FK Biofrontera AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Biofrontera Reaches Out-Of-Court Settlement With DUSA Pharmaceuticals

Nov 29 (Reuters) - BIOFRONTERA AG  B8FGn.DE :
    * REACHES OUT-OF-COURT SETTLEMENT WITH DUSA PHARMACEUTICALS,
INC.
    * COMPANY AS WELL AS ITS DEFENDANT SUBSIDIARIES HAVE AGREED
TO PAY
DUSA USD 22.5 MILLION IN SETTLEMENT OF POTENTIAL CLAIMS
    * FURTHER MUTUAL CLAIMS HAVE BEEN RELEASED
    * HALF OF SETTLEMENT AMOUNT IS DUE UPON EXECUTION OF
AGREEMENT,
THEREAFTER ONE QUARTER ON EACH OF FIRST AND SECOND ANNIVERSARIES
AFTER EXECUTION OF AGREEMENT
    * OF THIS AMOUNT, 50% WILL BE BORNE BY COMPANY AND 50% BY
BIOFRONTERA INC

Source text for Eikon:  ID:nPexWVKw1a 
Further company coverage:  B8FGn.DE 

 (Gdansk Newsroom)
 ((Gdansk.Newsroom@thomsonreuters.com;))

Recent news on Biofrontera AG

See all news